Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases

SHM Rooijakkers; JA van Strijp; CPM van Kessel; Willem J.B. van Wamel

Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases

SHM Rooijakkers (Inventor), JA van Strijp (Inventor), CPM van Kessel (Inventor), Willem J.B. van Wamel (Inventor)

Research output: Patent › Academic

Abstract

The present invention relates to the use of staphylococcal complement inhibitor (SCIN) or a homologue thereof, or a derivate or a fragment of SCIN or the SCIN homologue for the preparation of a medicament for intervening with C3 and C5 convertases. The medicament is in particular intended for inhibiting activation of the classical and/or the alternative pathway of complement. More in particular, the medicament is for treating indications that involve complement activation via the classical and/or alternative parthway.

Original language	English
Publication status	Published - 2006

Cite this

@misc{45ae2f57e1c644ae8243d9ab857cfdc7,

title = "Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases",

abstract = "The present invention relates to the use of staphylococcal complement inhibitor (SCIN) or a homologue thereof, or a derivate or a fragment of SCIN or the SCIN homologue for the preparation of a medicament for intervening with C3 and C5 convertases. The medicament is in particular intended for inhibiting activation of the classical and/or the alternative pathway of complement. More in particular, the medicament is for treating indications that involve complement activation via the classical and/or alternative parthway.",

author = "SHM Rooijakkers and {van Strijp}, JA and {van Kessel}, CPM and {van Wamel}, {Willem J.B.}",

year = "2006",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases

AU - Rooijakkers, SHM

AU - van Strijp, JA

AU - van Kessel, CPM

AU - van Wamel, Willem J.B.

PY - 2006

Y1 - 2006

N2 - The present invention relates to the use of staphylococcal complement inhibitor (SCIN) or a homologue thereof, or a derivate or a fragment of SCIN or the SCIN homologue for the preparation of a medicament for intervening with C3 and C5 convertases. The medicament is in particular intended for inhibiting activation of the classical and/or the alternative pathway of complement. More in particular, the medicament is for treating indications that involve complement activation via the classical and/or alternative parthway.

AB - The present invention relates to the use of staphylococcal complement inhibitor (SCIN) or a homologue thereof, or a derivate or a fragment of SCIN or the SCIN homologue for the preparation of a medicament for intervening with C3 and C5 convertases. The medicament is in particular intended for inhibiting activation of the classical and/or the alternative pathway of complement. More in particular, the medicament is for treating indications that involve complement activation via the classical and/or alternative parthway.

M3 - Patent

ER -

Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases

Abstract

Fingerprint

Cite this